0002067748-26-000001.txt : 20260123
0002067748-26-000001.hdr.sgml : 20260123
20260123133452
ACCESSION NUMBER: 0002067748-26-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering
FILED AS OF DATE: 20260123
DATE AS OF CHANGE: 20260123
EFFECTIVENESS DATE: 20260123
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PharmAdva, LLC
CENTRAL INDEX KEY: 0002067748
ORGANIZATION NAME:
EIN: 000000000
STATE OF INCORPORATION: NY
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-570991
FILM NUMBER: 26555324
BUSINESS ADDRESS:
STREET 1: 1565 JEFFERSON ROAD
STREET 2: SUITE 160
CITY: ROCHESTER
STATE: NY
ZIP: 14623
BUSINESS PHONE: 844-606-3474
MAIL ADDRESS:
STREET 1: 1565 JEFFERSON ROAD
STREET 2: SUITE 160
CITY: ROCHESTER
STATE: NY
ZIP: 14623
D
1
primary_doc.xml
X0708
D
LIVE
0002067748
PharmAdva, LLC
1565 JEFFERSON ROAD
SUITE 200
ROCHESTER
NY
NEW YORK
14623
844-606-3474
NEW YORK
None
None
Limited Liability Company
true
Jonathan
Sacks
1565 Jefferson Road
Suite 200
Rochester
NY
NEW YORK
14623
Director
Mark
Ambruster
1565 Jefferson Road
Suite 200
Rochester
NY
NEW YORK
14623
Director
Michael
Allen
1565 Jefferson Road
Suite 200
Rochester
NY
NEW YORK
14623
Director
Pamela
Schwitzer
1565 Jefferson Road
Suite 200
Rochester
NY
NEW YORK
14623
Director
Jim
Brush
1565 Jefferson Road
Suite 200
Rochester
NY
NEW YORK
14623
Director
Michael
Berg
1565 Jefferson Road
Suite 200
Rochester
NY
NEW YORK
14623
Executive Officer
Director
Joel
Reiser
1565 Jefferson Road
Suite 200
Rochester
NY
NEW YORK
14623
Director
Manufacturing
Decline to Disclose
- 06b
false
2026-01-21
false
true
false
25000
1000000
550000
450000
false
2
0
0
0
false
PharmAdva, LLC
/s/ Michel J. Berg, MD
Michel J. Berg, MD
President and CEO
2026-01-22